Systemic Mastocytosis with An Associated Hematologic Neoplasm
📧 Sign up to get email alerts when something new happens for Systemic Mastocytosis with An Associated Hematologic Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Avapritinib With Decitabine in Patients With SM-AHN [Phase 1]
Phase 1 study evaluating the combination of avapritinib and decitabine in patients with systemic mastocytosis with an associated hematologic…
-
CLINICAL_TRIALS withdrawal · 2024-06-28Clinical Trial Update: Managed Access Programs for PKC412, Midostaurin
This update indicates that Novartis' managed access programs for midostaurin (PKC412) are no longer available, impacting access for patients…
-
FDA approval · 2021-04-20FDA Approved: RYDAPT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for RYDAPT (midostaurin) from Novartis, updating the regulatory status of the product.